title: Recovery of coronary flow and left ventricular function after abciximab.
authors.affiliation: Department of Cardiology National Heart Centre, Tan Hospital, Singapore.
authors.forename: K H
authors.initials: KH
authors.lastname: Mak
authors.forename: F J
authors.initials: FJ
authors.lastname: Neumann
authors.forename: M R
authors.initials: MR
authors.lastname: Blasini
authors.forename: M C
authors.initials: MC
authors.lastname: Schmitt
authors.forename: M E
authors.initials: ME
authors.lastname: Alt
authors.forename: M J
authors.initials: MJ
authors.lastname: Dirschinger
authors.forename: M M
authors.initials: MM
authors.lastname: Gawaz
authors.forename: M A
authors.initials: MA
authors.lastname: Kastrati
authors.forename: M A
authors.initials: MA
authors.lastname: Schömig
mesh_terms: D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D003326:Coronary Circulation / Q000187:drug effects; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015607:Stents; D016277:Ventricular Function, Left / Q000187:drug effects
chemical_list: D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin; D000077284:Abciximab